Elsevier

The Lancet

Volume 369, Issue 9561, 17–23 February 2007, Pages 540-542
The Lancet

Comment
FDA draft guidance and health-outcomes research

https://doi.org/10.1016/S0140-6736(07)60250-5Get rights and content

First page preview

First page preview
Click to open first page preview

References (7)

There are more references available in the full text version of this article.

Cited by (79)

  • Evaluating response in gastroparesis: Patient reported outcome measures and survey instruments

    2020, Gastroparesis: Pathophysiology, Clinical Presentation, Diagnosis and Treatment
  • How to decide which patient-reported outcome measure to use? A practical guide for plastic surgeons

    2018, Journal of Plastic, Reconstructive and Aesthetic Surgery
    Citation Excerpt :

    It is important that we have patient-reported data to advocate certain treatments for patients, especially in the current climate where rationing of procedures is occurring. Many regulatory bodies also demand the inclusion of patient-reported data in applications.10 The drive for value-based healthcare requires the wider adoption of PROMs to measure health outcomes across different providers and healthcare settings,11,12 and the King's Fund report suggests that PROMs are likely to become “a key part of how health care is funded, provided and managed”.2

  • Ceramic biomaterials for tissue engineering

    2018, Fundamental Biomaterials: Ceramics
View all citing articles on Scopus
View full text